These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 29126843

  • 1. The role of platelet reactivity assessment in dual antiplatelet prophylaxis after transcatheter aortic valve implantation.
    Czerwińska-Jelonkiewicz K, Witkowski A, Dąbrowski M, Piotrowski W, Hryniewiecki T, Stępińska J.
    Arch Cardiovasc Dis; 2018 Apr; 111(4):233-245. PubMed ID: 29126843
    [Abstract] [Full Text] [Related]

  • 2. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents).
    Kirtane AJ, Parikh PB, Stuckey TD, Xu K, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Mazzaferri EL, Parvataneni R, Maehara A, Généreux P, Mehran R, Stone GW.
    JACC Cardiovasc Interv; 2015 Dec 28; 8(15):1978-1987. PubMed ID: 26738669
    [Abstract] [Full Text] [Related]

  • 3. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
    Rodés-Cabau J, Masson JB, Welsh RC, Garcia Del Blanco B, Pelletier M, Webb JG, Al-Qoofi F, Généreux P, Maluenda G, Thoenes M, Paradis JM, Chamandi C, Serra V, Dumont E, Côté M.
    JACC Cardiovasc Interv; 2017 Jul 10; 10(13):1357-1365. PubMed ID: 28527771
    [Abstract] [Full Text] [Related]

  • 4. Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify pre-op TIMI 45--a pilot study.
    Reed GW, Kumar A, Guo J, Aranki S, Shekar P, Agnihotri A, Maree AO, McLean DS, Rosenfield K, Cannon CP.
    Clin Cardiol; 2015 Feb 10; 38(2):92-8. PubMed ID: 25655085
    [Abstract] [Full Text] [Related]

  • 5. Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Zhou Y, Wang Y, Wu Y, Huang C, Yan H, Zhu W, Xu W, Zhang L, Zhu J.
    BMC Cardiovasc Disord; 2017 Jun 15; 17(1):157. PubMed ID: 28619104
    [Abstract] [Full Text] [Related]

  • 6. Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial.
    Jimenez Diaz VA, Tello-Montoliu A, Moreno R, Cruz Gonzalez I, Baz Alonso JA, Romaguera R, Molina Navarro E, Juan Salvadores P, Paredes Galan E, De Miguel Castro A, Bastos Fernandez G, Ortiz Saez A, Fernandez Barbeira S, Raposeiras Roubin S, Ocampo Miguez J, Serra Peñaranda A, Valdes Chavarri M, Cequier Fillat A, Calvo Iglesias F, Iñiguez Romo A.
    JACC Cardiovasc Interv; 2019 Jan 14; 12(1):22-32. PubMed ID: 30621974
    [Abstract] [Full Text] [Related]

  • 7. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study.
    Mangiacapra F, Patti G, Barbato E, Peace AJ, Ricottini E, Vizzi V, Gatto L, D'Ambrosio A, De Bruyne B, Wijns W, Di Sciascio G.
    JACC Cardiovasc Interv; 2012 Mar 14; 5(3):281-9. PubMed ID: 22440493
    [Abstract] [Full Text] [Related]

  • 8. Effects of P2Y12 receptor inhibition with or without aspirin on hemostatic system activation: a randomized trial in healthy subjects.
    Traby L, Kollars M, Kaider A, Eichinger S, Wolzt M, Kyrle PA.
    J Thromb Haemost; 2016 Feb 14; 14(2):273-81. PubMed ID: 26663880
    [Abstract] [Full Text] [Related]

  • 9. The STIB score: a simple clinical test to predict clopidogrel resistance.
    Legrand D, Barbato E, Chenu P, Magne J, Vrolix M, Wijns W, Legrand V, STIB investigators.
    Acta Cardiol; 2015 Oct 14; 70(5):516-21. PubMed ID: 26567810
    [Abstract] [Full Text] [Related]

  • 10. High on-treatment platelet reactivity in transcatheter aortic valve implantation patients.
    Polzin A, Schleicher M, Seidel H, Scharf RE, Merx MW, Kelm M, Zeus T.
    Eur J Pharmacol; 2015 Mar 15; 751():24-7. PubMed ID: 25641745
    [Abstract] [Full Text] [Related]

  • 11. Does the response to aspirin and clopidogrel vary over 6 months in patients with ischemic heart disease?
    Khanna V, Mikael R, Thayalasamy K, Sambu N, Dimitrov BD, Englyst N, Calver AL, Corbett S, Gray H, Simpson IA, Wilkinson JR, Curzen N.
    J Thromb Haemost; 2015 Jun 15; 13(6):920-30. PubMed ID: 25809653
    [Abstract] [Full Text] [Related]

  • 12. A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial.
    Sibbing D, Aradi D, Jacobshagen C, Gross L, Trenk D, Geisler T, Orban M, Gori T, Hadamitzky M, Merkely B, Kiss RG, Komócsi A, Dézsi CA, Thalmeier A, Löw A, Holdt L, Teupser D, Ince H, Felix SB, Parma R, Malek L, Horstkotte J, Baylacher M, Schwinger R, Rieber J, Mudra H, Hausleiter J, Huber K, Neumann FJ, Koltowski L, Huczek Z, Mehilli J, Massberg S, TROPICAL-ACS Investigators.
    Thromb Haemost; 2017 Jan 05; 117(1):188-195. PubMed ID: 27652610
    [Abstract] [Full Text] [Related]

  • 13. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
    Rosengart TK, Romeiser JL, White LJ, Fratello A, Fallon E, Senzel L, Shroyer AL.
    J Thorac Cardiovasc Surg; 2013 Nov 05; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
    [Abstract] [Full Text] [Related]

  • 14. Pre-procedural dual antiplatelet therapy and bleeding events following transcatheter aortic valve implantation (TAVI).
    Huczek Z, Kochman J, Grygier M, Parma R, Scislo P, Wilimski R, Ochala A, Lesiak M, Olasinska-Wisniewska A, Grabowski M, Mazurek T, Sibbing D, Filipiak KJ, Opolski G.
    Thromb Res; 2015 Jul 05; 136(1):112-7. PubMed ID: 26004748
    [Abstract] [Full Text] [Related]

  • 15. Switching acute coronary syndrome patients from prasugrel to clopidogrel.
    Kerneis M, Silvain J, Abtan J, Cayla G, O'Connor SA, Barthélémy O, Vignalou JB, Beygui F, Brugier D, Martin R, Collet JP, Montalescot G.
    JACC Cardiovasc Interv; 2013 Feb 05; 6(2):158-65. PubMed ID: 23428007
    [Abstract] [Full Text] [Related]

  • 16. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aitmokhtar O, Paganelli F, Benamara S, Azaza A, Bonello L, Hamza O, Seddiki S, Benathmane T, Saidane M, Bouzid A, Kara M, Sik A, Azzouz A, Harbi F, Monsuez JJ, Benkhedda S.
    Arch Cardiovasc Dis; 2017 Nov 05; 110(11):626-633. PubMed ID: 28583820
    [Abstract] [Full Text] [Related]

  • 17. Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study.
    Giustino G, Redfors B, Kirtane AJ, Mehran R, Dangas GD, Witzenbichler B, Neumann FJ, Weisz G, Généreux P, Maehara A, McAndrew T, Farhan S, Rinaldi MJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL, Brodie BR, Stuckey TD, Gurbel P, Ben-Yehuda O, Stone GW.
    JACC Cardiovasc Interv; 2018 Jul 09; 11(13):1277-1286. PubMed ID: 29908967
    [Abstract] [Full Text] [Related]

  • 18. The effect of acenocoumarol on the antiplatelet effect of clopidogrel.
    Dewilde WJ, Janssen PW, Bergmeijer TO, Kelder JC, Hackeng CM, ten Berg JM.
    Thromb Haemost; 2015 Oct 09; 114(4):708-16. PubMed ID: 26177793
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
    Patti G, Pasceri V, Vizzi V, Ricottini E, Di Sciascio G.
    Am J Cardiol; 2011 Apr 01; 107(7):995-1000. PubMed ID: 21256470
    [Abstract] [Full Text] [Related]

  • 20. A randomised study for optimising crossover from ticagrelor to clopidogrel in patients with acute coronary syndrome. The CAPITAL OPTI-CROSS Study.
    Pourdjabbar A, Hibbert B, Chong AY, Le May MR, Labinaz M, Simard T, Ramirez FD, Lugomirski P, Maze R, Froeschl M, Glover C, Dick A, Marquis JF, Bernick J, Wells G, So DY, CAPITAL Investigators.
    Thromb Haemost; 2017 Jan 26; 117(2):303-310. PubMed ID: 27761582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.